Bruker Corp (FRA:BKD)
€ 59.28 1.32 (2.28%) Market Cap: 8.99 Bil Enterprise Value: 10.02 Bil PE Ratio: 23.53 PB Ratio: 6.64 GF Score: 95/100

Bruker Corp at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 03:30PM GMT
Release Date Price: €63 (-6.67%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Perfect. Hi, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team at JPMorgan. Today, I have the Bruker team with me. This session will start off with a 20-, 25-minute presentation followed by 20 to 15 minutes of Q&A. So with that, I have Frank to kick it off with their presentation. Thank you.

Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

Thank you very much, Rachel, for having us here. Thank you to all of you to braving the elements and coming here somehow this morning at this early hour. Our CFO, Gerald Herman, is here, our President of our Bruker Nano business. Mark Munch, he will also be joining Q&A and one of the. If you have any questions about IR, Senior Director, Justin Ward's in the audience, I'd like to acknowledge 2 of our Board members, Bonnie Anderson and Adelene Perkins. Thank you joining us. Good to see so many of you here.

Well, let me jump right in. This will be more of an update presentation.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot